Literature DB >> 25416235

Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.

Victoria Pechey1, John Parratt, Linh Vo, William Stevenson.   

Abstract

Graft-versus-host disease (GVHD) of the central nervous system is a rare complication following allogeneic haematopoietic stem cell transplant (HSCT). It is a challenging disease process to confirm as biopsies of the involved tissues can be difficult to obtain safely, the clinical presentation can be non-specific and the differential diagnosis includes infection, drug toxicities, metabolic encephalopathy and disease relapse. We report a case of meningeal graft-versus-host disease in a young woman with relapsed acute myeloid leukaemia after a sibling allogeneic HSCT. The GVHD responded to immunosuppression with resolution of the clinical symptoms and radiological findings and has remained quiescent after a second allogeneic HSCT from an unrelated matched donor.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25416235     DOI: 10.1007/s12185-014-1704-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  20 in total

Review 1.  Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.

Authors:  Oliver Grauer; Daniel Wolff; Hartmut Bertz; Hildegard Greinix; Jörn-Sven Kühl; Anita Lawitschka; Stephanie J Lee; Steven Z Pavletic; Ernst Holler; Ingo Kleiter
Journal:  Brain       Date:  2010-09-15       Impact factor: 13.501

2.  Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation.

Authors:  C S Padovan; A Gerbitz; P Sostak; E Holler; J L Ferrara; K Bise; A Straube
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

3.  Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantation.

Authors:  M Terrettaz; F Verholen; J Passweg; S Knipp; P R Burkhard; Y Chalandon
Journal:  Bone Marrow Transplant       Date:  2007-11-12       Impact factor: 5.483

4.  Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.

Authors:  Ali G Saad; Edwin P Alyea; Patrick Y Wen; Umberto Degirolami; Santosh Kesari
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

5.  Cerebral vasculitis in graft-versus-host disease: a case report.

Authors:  John N Campbell; P Pearse Morris
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

6.  Central nervous system graft-versus-host disease: report of two cases and literature review.

Authors:  R T Kamble; C-C Chang; S Sanchez; G Carrum
Journal:  Bone Marrow Transplant       Date:  2006-11-13       Impact factor: 5.483

7.  Subacute panencephalitis associated with chronic graft-versus-host disease.

Authors:  Y Iwasaki; K Sako; Y Ohara; M Miyazawa; M Minegishi; S Tsuchiya; T Konno
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  CNS angiitis in graft vs host disease.

Authors:  M Ma; G Barnes; J Pulliam; D Jezek; R J Baumann; J R Berger
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

9.  In vivo imaging of graft-versus-host-disease in mice.

Authors:  Angela Panoskaltsis-Mortari; Andrew Price; John R Hermanson; Elizabeth Taras; Chris Lees; Jonathan S Serody; Bruce R Blazar
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

10.  Cerebral angiitis in four patients with chronic GVHD.

Authors:  P Sostak; C S Padovan; S Eigenbrod; S Roeber; S Segerer; C Schankin; S Siegert; T Saam; D Theil; H-J Kolb; H Kretzschmar; A Straube
Journal:  Bone Marrow Transplant       Date:  2009-11-16       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.